Record the actual time and outcome rather than assuming an alert meant a medicine was taken.
Medication and mood recording
See medication and wellbeing in the same personal record.
Remembering medication is only part of the picture. Recording when it was taken alongside mood, energy, symptoms, side effects and effectiveness can help you describe what has been happening between appointments.
Available foriPhone
Available forAndroid
Available forAndroid~40%estimated medication non-adherence among people living with bipolar disorder.
This estimate comes from a systematic review. Non-adherence was associated with relapse, hospital admission and increased suicide risk, but these outcomes have many interacting causes. This is not an individual prediction or a claim that MediMAR prevents them. Read the review →
Why continuity matters
Medication difficulties can be an important part of a much wider picture.
A systematic review of schizophrenia research identified lack of insight, medication beliefs and substance use among important influences on adherence. Across the reviewed studies, non-adherence was associated with relapse, hospitalisation and suicide; hospitalisation was the most frequently reported consequence.
These are associations across groups—not proof that a missed dose caused a particular outcome. Side effects, access, symptoms, stressful events, substance use, personal circumstances and the suitability of treatment can all matter.
Read the systematic review →A combined record
Capture what happened—not just what was scheduled.
Add a personal mood check-in and optional notes when it is useful to you.
Record observations and optionally link them to a medication for easier review later.
Note your own experience of whether a medicine or treatment appears to be helping.
Keep entered readings such as blood pressure, weight or temperature with your diary.
Prepare a personal report to support a conversation, and choose if and when to share it.
Clinical guidance
A record can support care, but it cannot replace it.
NICE advises that suspected relapse in established psychosis or schizophrenia should be handled through the crisis section of the person’s care plan. It also identifies medication non-adherence, intolerable side effects and risk to self or others as reasons to consider referral back to specialist services.
Make medication decisions with your care team
Read the NICE recommendations →Do not stop, restart, reduce or increase prescribed mental health medication because of an app entry or information on this page. Speak to the professional responsible for your treatment.
Urgent support
MediMAR is not a crisis or monitoring service.
It does not assess risk, watch entries, contact your care team or summon help. If you or someone else is in immediate danger, call 999 or go to A&E. For urgent mental health help in England, use NHS 111 online or call 111 and select the mental health option. If you have a care or crisis plan, follow the contact instructions in it.
Using a personal medication and mood record
Can MediMAR tell whether my mood is changing because of a medicine?
No. MediMAR records the information you enter but does not diagnose a condition, interpret a mood change or establish what caused it. A healthcare professional can consider your record alongside other clinical information.
Will my care team be alerted if I miss a dose or record a low mood?
No. MediMAR is a personal record and does not monitor you or automatically alert your care team, family or emergency services.
Should I stop a medicine if I think it is affecting my mood?
Do not stop, restart or change prescribed medication without advice from the professional responsible for your treatment. Some medicines need to be changed gradually and safely.
Can I share a MediMAR report?
You can choose to show or share a report with someone supporting your care. It is a personal record based on information entered in the app, not a verified clinical record.
iPhone and Android
Keep me informed →Bring medication and personal observations together.
MediMAR is being prepared for independent testing and release.
Available foriPhoneAvailable forAndroid
Available forAndroid